Control of gastric acid secretion by histamine H2-receptor antagonists; a pharmacological dream come true.
D000284:Administration, Oral; D000818:Animals; D003365:Costs and Cost Analysis; D003864:Depression, Chemical; D004353:Drug Evaluation, Preclinical; D005750:Gastric Juice / Q000378:metabolism*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D010418:Pentagastrin / Q000037:antagonists & inhibitors; D010437:Peptic Ulcer / Q000188:drug therapy / Q000503:physiopathology; D011955:Receptors, Drug; D012636:Secretory Rate / Q000187:drug effects; D013440:Sulfides / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D013890:Thiourea / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity
D007093:Imidazoles; D011955:Receptors, Drug; D013440:Sulfides; D010418:Pentagastrin; D013890:Thiourea